BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38110515)

  • 1. Risk stratification utilizing sequential organ failure assessment (SOFA) score, antithrombin activity, and demographic data in sepsis-associated disseminated intravascular coagulation (DIC).
    Iba T; Maier CL; Tanigawa T; Levy JH
    Sci Rep; 2023 Dec; 13(1):22502. PubMed ID: 38110515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Tanigawa T; Wada H; Levy JH
    Thromb J; 2023 Nov; 21(1):112. PubMed ID: 37919722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation.
    Iba T; Arakawa M; Mochizuki K; Nishida O; Wada H; Levy JH
    Clin Appl Thromb Hemost; 2019; 25():1076029618824044. PubMed ID: 30808223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure.
    Kuroda H; Masuda Y
    Clin Appl Thromb Hemost; 2020; 26():1076029620981630. PubMed ID: 33332196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Saitoh D; Gando S; Thachil J
    Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation.
    Iba T; Arakawa M; Ohchi Y; Arai T; Sato K; Wada H; Levy JH
    Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):145S-149S. PubMed ID: 30198317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of the simplified JSTH score criteria in the early diagnosis of sepsis-associated disseminated intravascular coagulation].
    Wang YY; Wan XH; Huang QQ; Wang G; Wan LJ; Liu OY
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(11):837-841. PubMed ID: 32234155
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection.
    Choi Q; Hong KH; Kim JE; Kim HK
    Ann Lab Med; 2014 Mar; 34(2):85-91. PubMed ID: 24624342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
    Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
    Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining prognostic indicator for anticoagulant therapy in sepsis-induced disseminated intravascular coagulation.
    Iba T; Yamakawa K; Shiko Y; Hisamune R; Tanigawa T; Helms J; Levy JH
    J Intensive Care; 2024 Jun; 12(1):24. PubMed ID: 38915122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of antithrombin III supplementation in an overt disseminated intravascular coagulation: a longitudinal single-institutional experience and retrospective analysis.
    Lee S; Kim J; Ji M; Moon H; Lee W
    Ann Palliat Med; 2024 May; 13(3):477-495. PubMed ID: 38735696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
    Akahoshi T; Kaku N; Shono Y; Yamamoto Y; Takahashi K; Iyonaga T; Momii K; Nishihara M; Maki J; Tokuda K; Yamaura K
    Clin Appl Thromb Hemost; 2022; 28():10760296221135790. PubMed ID: 36380520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the value of prothrombin time for predicting the severity and prognosis of septic patients].
    Bai H; Shen L; Jing L; Liu W; Sun Z; Tang N
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jul; 34(7):682-688. PubMed ID: 36100403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan.
    Yamakawa K; Umemura Y; Hayakawa M; Kudo D; Sanui M; Takahashi H; Yoshikawa Y; Hamasaki T; Fujimi S;
    Crit Care; 2016 Jul; 20(1):229. PubMed ID: 27472991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Suggested Link Between Antithrombin Dose and Rate of Recovery from Disseminated Intravascular Coagulation in Patients with Severe Organ Failure.
    Kuroda H; Tatsumi H; Sonoda T; Masuda Y
    Clin Appl Thromb Hemost; 2022; 28():10760296221080942. PubMed ID: 35187966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Gando S; Saitoh D; Wada H; Di Nisio M; Thachil J
    Thromb Res; 2016 Sep; 145():46-50. PubMed ID: 27479532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin concentrate use in sepsis-associated disseminated intravascular coagulation: re-evaluation of a 'pendulum effect' drug using a nationwide database.
    Tagami T
    J Thromb Haemost; 2018 Mar; 16(3):458-461. PubMed ID: 29316251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation.
    Iba T; Hagiwara A; Saitoh D; Anan H; Ueki Y; Sato K; Gando S
    Ann Intensive Care; 2017 Nov; 7(1):110. PubMed ID: 29098447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.